Adenovirus type 4 a

Ended Awarded

Contract number
SPE2DP21F0999
Awardee
Awarding agency
Obligated
$542,988

Award facts

Opportunity
Contract value 100% obligated
$542,988.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed Only One Source
Pricing
Firm Fixed Price
Place of performance
Parsippany, NJ 07054, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

Teva Pharmaceuticals USA, Inc. was awarded a $542,988 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to supply adenovirus type 4. The contract was issued under an indefinite-delivery/indefinite-quantity medical product contract vehicle held by DLA. Teva will deliver the pharmaceutical product to a location in Parsippany, New Jersey between December 7-15, 2020. No subcontractors or set-aside designations were identified. This award supports DLA's mission to procure medical supplies for the U.S. Department of Defense.

Quick answers

Who was awarded contract SPE2DP21F0999?

SPE2DP21F0999 was awarded to Teva Pharmaceuticals Usa, Inc. by Medical Supply Chain (Troop Support) on December 7, 2020.

How much is contract SPE2DP21F0999 worth?

The government has obligated $542,988 on SPE2DP21F0999.

Is contract SPE2DP21F0999 an order under another contract?

Yes. SPE2DP21F0999 is a delivery order under SPE2DP20D0002, an indefinite delivery contract.

Was contract SPE2DP21F0999 competed?

The extent of competition for SPE2DP21F0999 was not competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login